U.S. Sustainable Fund Flows Contract Again in 2023’s First Quarter
IShares fund accounts for nearly all withdrawals. New GMO fund gains inflows.
Megan Pacholok
Megan Pacholok is a senior manager research analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers multi-asset funds and college savings plans and is a regular contributor to Morningstar's asset-allocation thought leadership.
Before joining Morningstar Research Services in 2019, she worked as a product consultant for Morningstar Direct.
Pacholok holds a bachelor's degree in finance and economics from DePaul University.
Latest
Has Vanguard’s Target-Date Fund Series Lost Its Edge?
Two Morningstar analysts discuss the outlook for the largest target-date fund series.
Mar 29, 2023
The Best Target-Date Funds for 2023 and Beyond
Five series earn the coveted Morningstar Analyst Rating of Gold.
Mar 28, 2023
The Top Female Portfolio Managers to Invest With Now
Morningstar’s highest-rated female portfolio managers have shattered glass ceilings across asset classes.
Mar 6, 2023
American Funds Garners the Most Target-Date Mutual Fund Flows in 2022
Fidelity and Vanguard round out the top three.
Jan 19, 2023
ABCs of HSAs for 2023
Sep 20, 2022
ABCs of HSAs for 2023
Sep 20, 2022
New 401(k) Lawsuits Go Too Far
If successful, performance-chasing could be the hot new trend in 401(k) lineups.
Sep 7, 2022
The ABCs of Target-Date Funds
Apr 7, 2022
The ABCs of Target-Date Funds
Apr 7, 2022
Target-Date Deep Dive: American Funds
Mar 29, 2022
Target-Date Deep Dive: American Funds
Mar 29, 2022
The Best Target-Date Funds for 2022 and Beyond
Only one series earned an upgrade to the coveted Gold-medalist ranking this year.
Mar 23, 2022
How Much Risk Is Your Target-Date Fund Taking?
Mar 23, 2022
BlackRock LifePath Index Target-Date Series
This remains a first-class target-date series.
Mar 14, 2022